{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:14:22Z","timestamp":1790712862060,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074039"],"award-info":[{"award-number":["82074039"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204584"],"award-info":[{"award-number":["82204584"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004835","name":"Zhejiang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004835","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jpha.2022.11.006","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T11:53:59Z","timestamp":1669031639000},"page":"187-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["PKM2-mediated neuronal hyperglycolysis enhances the risk of Parkinson's disease in diabetic rats"],"prefix":"10.1016","volume":"13","author":[{"given":"Ya","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cimin","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6631-9386","authenticated-orcid":false,"given":"Rui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3541-7132","authenticated-orcid":false,"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghui","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3212-568X","authenticated-orcid":false,"given":"Tengfei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2022.11.006_bib1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.chom.2020.06.008","article-title":"The microbiome as a modifier of neurodegenerative disease risk","volume":"28","author":"Fang","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jpha.2022.11.006_bib2","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1016\/j.apsb.2021.02.016","article-title":"Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jpha.2022.11.006_bib3","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.apsb.2021.03.020","article-title":"Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4\/MyD88\/NF-\u03baB pathway through microbiota-gut-brain axis","volume":"11","author":"Zhao","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jpha.2022.11.006_bib4","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jpha.2022.11.006_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.apsb.2015.07.009","article-title":"5'-Monophosphate-activated protein kinase (AMPK) improves autophagic activity in diabetes and diabetic complications","volume":"6","author":"Yao","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jpha.2022.11.006_bib6","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.apsb.2012.06.001","article-title":"AMPK in myocardial infarction and diabetes: The Yin\/Yang effect","volume":"2","author":"Moussa","year":"2012","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jpha.2022.11.006_bib7","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1016\/j.apsb.2021.09.031","article-title":"PXR activation impairs hepatic glucose metabolism partly via inhibiting the HNF4\u03b1-GLUT2 pathway","volume":"12","author":"Liu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jpha.2022.11.006_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mds.27836","article-title":"Understanding the links between cardiovascular disease and Parkinson's disease","volume":"35","author":"Potashkin","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jpha.2022.11.006_bib9","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/brain\/awaa262","article-title":"Diabetes medications and risk of Parkinson's disease: A cohort study of patients with diabetes","volume":"143","author":"Brauer","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.jpha.2022.11.006_bib10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/mds.27941","article-title":"Diabetes, BMI, and Parkinson's","volume":"35","author":"Foltynie","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jpha.2022.11.006_bib11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3233\/JPD-191900","article-title":"The association between type 2 diabetes mellitus and Parkinson's disease","volume":"10","author":"Cheong","year":"2020","journal-title":"J.\u00a0Parkinsons Dis."},{"key":"10.1016\/j.jpha.2022.11.006_bib12","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.clnu.2018.05.018","article-title":"Clinical and metabolic response to probiotic administration in people with Parkinson's disease: A randomized, double-blind, placebo-controlled trial","volume":"38","author":"Tamtaji","year":"2019","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.jpha.2022.11.006_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21165895","article-title":"Possible neuroprotective mechanisms of physical exercise in neurodegeneration","volume":"21","author":"Mahalakshmi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2022.11.006_bib14","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S2213-8587(20)30113-3","article-title":"Central nervous pathways of insulin action in the control of metabolism and food intake","volume":"8","author":"Kullmann","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.jpha.2022.11.006_bib15","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00401-018-1832-0","article-title":"Interaction of amyloidogenic proteins in pancreatic \u03b2 cells from subjects with synucleinopathies","volume":"135","author":"Martinez-Valbuena","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jpha.2022.11.006_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-021-01171-0","article-title":"Mixed pathologies in pancreatic \u03b2 cells from subjects with neurodegenerative diseases and their interaction with prion protein","volume":"9","author":"Martinez-Valbuena","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jpha.2022.11.006_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031059","article-title":"Synergistic effects of milk-derived exosomes and galactose on \u03b1-synuclein pathology in Parkinson\u2019s disease and type 2 diabetes mellitus","volume":"22","author":"Melnik","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2022.11.006_bib18","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005475","article-title":"Diabetes mellitus and Parkinson disease","volume":"90","author":"Pagano","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jpha.2022.11.006_bib19","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1021\/acs.chemrev.0c01122","article-title":"Amyloid oligomers: A joint experimental\/computational perspective on Alzheimer's disease, Parkinson's disease, type II diabetes, and amyotrophic lateral sclerosis","volume":"121","author":"Nguyen","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jpha.2022.11.006_bib20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4103\/1673-5374.320965","article-title":"Diabetes mellitus and Parkinson's disease: Dangerous liaisons between insulin and dopamine","volume":"17","author":"De Iuliis","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jpha.2022.11.006_bib21","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/mds.27802","article-title":"Update of the MDS research criteria for prodromal Parkinson's disease","volume":"34","author":"Heinzel","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jpha.2022.11.006_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/mds.25208","article-title":"Reply to: Diabetes and risk of Parkinson\u2019s disease","volume":"28","author":"Palacios","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jpha.2022.11.006_bib23","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2337\/dc20-3006","article-title":"Associations between exposure to gestational diabetes mellitus in utero and daily energy intake, brain responses to food cues, and adiposity in children","volume":"44","author":"Luo","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpha.2022.11.006_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2017.00355","article-title":"Multiple evidences for association between cognitive impairment and dysglycemia in Parkinson\u2019s disease: Implications for clinical practice","volume":"9","author":"Yang","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jpha.2022.11.006_bib25","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1126\/science.aam9080","article-title":"Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease","volume":"357","author":"Burbulla","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jpha.2022.11.006_bib26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bbi.2018.03.005","article-title":"Neuroinflammatory priming to stress is differentially regulated in male and female rats","volume":"70","author":"Fonken","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jpha.2022.11.006_bib27","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2174\/1570159X19666210809103346","article-title":"Phytochemicals targeting oxidative stress, interconnected neuroinflammatory, and neuroapoptotic pathways following radiation","volume":"20","author":"Fakhri","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jpha.2022.11.006_bib28","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1212\/WNL.0000000000005771","article-title":"Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study","volume":"91","author":"De Pablo-Fernandez","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jpha.2022.11.006_bib29","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007458","article-title":"Reader response: Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study","volume":"92","author":"Lai","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.jpha.2022.11.006_bib30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41581-019-0135-6","article-title":"Epigenetics and epigenomics in diabetic kidney disease and metabolic memory","volume":"15","author":"Kato","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jpha.2022.11.006_bib31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.preteyeres.2010.09.001","article-title":"Dietary hyperglycemia, glycemic index and metabolic retinal diseases","volume":"30","author":"Chiu","year":"2011","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jpha.2022.11.006_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3322\/caac.21670","article-title":"Metabolomics in cancer research and emerging applications in clinical oncology, CA","volume":"71","author":"Schmidt","year":"2021","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.jpha.2022.11.006_bib33","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/s41592-021-01303-3","article-title":"Metabolite discovery through global annotation of untargeted metabolomics data","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jpha.2022.11.006_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneumeth.2004.10.004","article-title":"Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease","volume":"144","author":"Yuan","year":"2005","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.jpha.2022.11.006_bib35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000480474","article-title":"Effect of shikonin on spinal cord injury in rats via regulation of HMGB1\/TLR4\/NF-kB signaling pathway","volume":"43","author":"Bi","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.jpha.2022.11.006_bib36","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","article-title":"Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease","volume":"24","author":"Yun","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpha.2022.11.006_bib37","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/mds.27077","article-title":"Ceftriaxone reduces L-dopa-induced dyskinesia severity in 6-hydroxydopamine parkinson's disease model","volume":"32","author":"Chotibut","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jpha.2022.11.006_bib38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A\u00a0highly reproducible rotenone model of Parkinson's disease","volume":"34","author":"Cannon","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jpha.2022.11.006_bib39","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0893-133X(98)00079-7","article-title":"Susceptibility to amphetamine-induced locomotor sensitization is modulated by environmental stimuli","volume":"20","author":"Fraioli","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpha.2022.11.006_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040958","article-title":"PC12 cell line: Cell types, coating of culture vessels, differentiation and other culture conditions","volume":"9","author":"Wiatrak","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jpha.2022.11.006_bib41","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/0024-3205(93)90469-J","article-title":"Comparison of antitumor activity of vitamins K1, K2 and K3 on human tumor cells by two (MTT and SRB) cell viability assays","volume":"52","author":"Wu","year":"1993","journal-title":"Life Sci."},{"key":"10.1016\/j.jpha.2022.11.006_bib42","doi-asserted-by":"crossref","unstructured":"X. Song, J. Liu, F. Kuang, et\u00a0al., PDK4 dictates metabolic resistance to ferroptosis by suppressing pyruvate oxidation and fatty acid synthesis, Cell Rep. 34 (2021), 108767.","DOI":"10.1016\/j.celrep.2021.108767"},{"key":"10.1016\/j.jpha.2022.11.006_bib43","article-title":"High glucose activated cardiac fibroblasts by a disruption of mitochondria-associated membranes","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jpha.2022.11.006_bib44","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/mt.2014.206","article-title":"Enhanced efficacy of the CDNF\/MANF family by combined intranigral overexpression in the 6-OHDA rat model of Parkinson's disease","volume":"23","author":"Cordero-Llana","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jpha.2022.11.006_bib45","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-018-1289-z","article-title":"NOD2 promotes dopaminergic degeneration regulated by NADPH oxidase 2 in 6-hydroxydopamine model of Parkinson\u2019s disease","volume":"15","author":"Cheng","year":"2018","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.jpha.2022.11.006_bib46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.actbio.2016.09.011","article-title":"Regenerative effects of peptide nanofibers in an experimental model of Parkinson's disease","volume":"46","author":"Sever","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jpha.2022.11.006_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2022.02.013","article-title":"Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer's disease","volume":"34","author":"Pan","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.jpha.2022.11.006_bib48","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1038\/onc.2011.137","article-title":"Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2","volume":"30","author":"Chen","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.jpha.2022.11.006_bib49","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.2337\/db15-1670","article-title":"Bezafibrate improves insulin sensitivity and metabolic flexibility in STZ-induced diabetic mice","volume":"65","author":"Franko","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jpha.2022.11.006_bib50","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ymthe.2020.10.025","article-title":"Lentivirus mediated pancreatic beta-cell-specific insulin gene therapy for STZ-induced diabetes","volume":"29","author":"Erendor","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jpha.2022.11.006_bib51","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/mds.28124","article-title":"Diabetes causes dysfunctional dopamine neurotransmission favoring nigrostriatal degeneration in mice","volume":"35","author":"P\u00e9rez-Taboada","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jpha.2022.11.006_bib52","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3233\/JPD-202486","article-title":"Diabetes mellitus is associated with a higher relative risk for Parkinson's disease in women than in men","volume":"11","author":"Deischinger","year":"2021","journal-title":"J.\u00a0Parkinsons Dis."},{"key":"10.1016\/j.jpha.2022.11.006_bib53","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/mds.28551","article-title":"Type 2 diabetes as a determinant of Parkinson's disease risk and progression","volume":"36","author":"Chohan","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jpha.2022.11.006_bib54","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/mds.27922","article-title":"Body mass index, diabetes, and the risk of Parkinson's disease","volume":"35","author":"Jeong","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jpha.2022.11.006_bib55","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/mas.20221","article-title":"Glycoproteomics in neurodegenerative diseases","volume":"29","author":"Hwang","year":"2010","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.jpha.2022.11.006_bib56","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41531-021-00184-9","article-title":"Serum metabolic biomarkers for synucleinopathy conversion in isolated REM sleep behavior disorder","volume":"7","author":"Laguna","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.jpha.2022.11.006_bib57","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/mds.27037","article-title":"Aging and Parkinson's disease: Different sides of the same coin?","volume":"32","author":"Collier","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jpha.2022.11.006_bib58","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.4103\/1673-5374.332122","article-title":"Parkinson's disease and diabetes mellitus: Common mechanisms and treatment repurposing","volume":"17","author":"Labandeira","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jpha.2022.11.006_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/729194","article-title":"Metabolic syndrome: An important risk factor for Parkinson's disease","volume":"2014","author":"Zhang","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.jpha.2022.11.006_bib60","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","article-title":"Diabetic neuropathy: Clinical manifestations and current treatments","volume":"11","author":"Callaghan","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jpha.2022.11.006_bib61","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3892\/ijmm.2013.1604","article-title":"Formation of a salsolinol-like compound, the neurotoxin, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, in a cellular model of hyperglycemia and a rat model of diabetes","volume":"33","author":"Song","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jpha.2022.11.006_bib62","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-020-01605-y","article-title":"PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma","volume":"39","author":"Martin","year":"2020","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jpha.2022.11.006_bib63","first-page":"3575","article-title":"Inhibition of BAG3 enhances the anticancer effect of shikonin in hepatocellular carcinoma","volume":"11","author":"Lu","year":"2021","journal-title":"Am. J. Cancer Res."}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177922001198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177922001198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:33:42Z","timestamp":1761860022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177922001198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2095177922001198"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2022.11.006","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PKM2-mediated neuronal hyperglycolysis enhances the risk of Parkinson's disease in diabetic rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2022.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of Xi\u2019an Jiaotong University.","name":"copyright","label":"Copyright"}]}}